Business Context and Reporting Period
This Form 8-K is a current report filed by Trovagene, Inc. (not Cardiff Oncology, Inc.) on March 20, 2018. The registrant is a Delaware corporation headquartered in San Diego, CA. The filing reports a corporate event scheduled for March 22, 2018.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is an event notification and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document solely announces a scheduled presentation at an investor conference.
Guidance, Outlook, and Events
- Upcoming Event: Trovagene, Inc. announced it will present at The Wall Street Investor Forum 26th Annual Investor Conference.
- Date and Time: Thursday, March 22, 2018, at 2:05 PM EDT / 11:05 AM PDT.
- Location: The University Club of NYC, New York City.
- Management Commentary: The filing includes a press release (Exhibit 99.1) regarding the presentation but contains no specific operational guidance or risk factors within the main text.
Investor Verification Checklist
- Verify the correct registrant name is Trovagene, Inc., as the input metadata referenced Cardiff Oncology, Inc.
- Confirm the presentation details (time and location) for the March 22, 2018 conference.
- Review the attached press release (Exhibit 99.1) for any specific updates on clinical trials or business strategy not detailed in the 8-K summary.
- Note that no financial data is available in this specific filing; refer to the most recent 10-K or 10-Q for financial metrics.